Renagel
Product Images NDC 68151-4295

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Renagel (NDC 68151-4295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681514295)

Renagel is a medication that contains sevelamer HCL in tablet form with each tablet containing 400mg. It is manufactured by Genzyme with a lot number of B6588BG1 and an expiration date of 112/47. The medication is only available for prescription and has an NDC number of 58468-0028-61. The text also includes an illegible code number at the bottom.*

FDA Label Image

Figure 1 (Renagel 01)

FDA Label Image

Figure 2 (Renagel 02)

This appears to be a graph or chart related to a medical study/trial involving a medication called Sevelamer Hydrochloride and its effects on reducing serum phosphorus levels in patients. The graph shows a reduction from baseline levels over time and suggests that the medication is effective in improving patients' conditions.*

FDA Label Image

Figure 3 (Renagel 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.